Reference health
Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registry
33/33 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 33 checked references that resolve
resolves10.1002/art.37715
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
resolves10.1002/art.20077
Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg‐Strauss syndrome in a French urban multiethnic population in 2000: A capture–recapture estimate
resolves10.1002/art.1780390112
The epidemiology of Wegener's granulomatosis. Estimates of the five‐year period prevalence, annual mortality, and geographic disease distribution from population‐based data sources
resolves10.1136/emj.20.1.54
Observational research methods. Research design II: cohort, cross sectional, and case-control studies
resolves10.1093/aje/kwz066
Counterpoint: Keeping the Demons at Bay When Handling Time-Varying Exposures—Beyond Avoiding Immortal Person-Time
resolves10.1136/annrheumdis-2018-214544
Time-dependent biases in observational studies of comparative effectiveness research in rheumatology. A methodological review
resolves10.1002/art.1780330807
The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis
resolves10.1136/annrheumdis-2015-207841
Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance
resolves10.7326/M19-3827
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
resolves10.1056/NEJMoa1404231
Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
resolves10.1001/jama.2010.1658
Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
resolves10.1056/NEJMoa0802311
Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis
resolves10.1002/art.39011
Treatment of Systemic Necrotizing Vasculitides in Patients Aged Sixty‐Five Years or Older: Results of a Multicenter, Open‐Label, Randomized Controlled Trial of Corticosteroid and Cyclophosphamide–Based Induction Therapy
resolves10.1056/NEJMoa1803537
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
resolves10.1136/ard.2006.062711
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis
resolves10.1002/art.34562
Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis
resolves10.1097/MD.0000000000006083
Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides
resolves10.1002/art.39812
Myeloperoxidase–Antineutrophil Cytoplasmic Antibody (ANCA)–Positive and ANCA‐Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets
resolves10.1002/art.39786
Myeloperoxidase–Antineutrophil Cytoplasmic Antibody (ANCA)–Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA‐Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center
resolves10.1093/rheumatology/key117
Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients
resolves10.1136/ard.2010.130203
Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?
resolves10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J
An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients
resolves10.1136/annrheumdis-2012-201750
Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis
resolves10.1136/annrheumdis-2016-210942
Mortality in ANCA-associated vasculitis: ameta-analysis of observational studies
resolves10.3899/jrheum.190065
Prevalence and Risk Factors for Major Infections in Patients with Antineutrophil Cytoplasmic Antibody–associated Vasculitis: Influence on the Disease Outcome
resolves10.1093/rheumatology/kez575
Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group
resolves10.1136/bmjopen-2017-018748
Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial
resolves10.1136/annrheumdis-2017-212861
Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis
The 3 references without a DOI — listed, not checked
no DOI — not checkedComparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts
no DOI — not checkedBirmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis
no DOI — not checkedInfliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.semarthrit.2021.02.002"><img src="https://citestamp.com/citestamped/10.1016/j.semarthrit.2021.02.002/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.semarthrit.2021.02.002)